ctrl K

Price Alert

Onconova Therapeutics Inc... (ONTX)

NASDAQ: ONTX · Real-Time Price · USD

1.00

0.00 (0.00%)

At close: Apr 02, 2024, 10:00 PM

Onconova Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21,338B	20.82M	38.76M	55.07M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1B	1K	1K	10K
Receivables	n/a	18K	29K	28K
Inventory	n/a	1.42M	97K	29K
Other Current Assets	3,613B	401K	561K	332K
Total Current Assets	24,951B	22.66M	39.35M	55.43M
Property-Plant & Equipment	10B	22K	24K	38K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	11B	23K	25K	48K
Total Assets	24,962B	22.68M	39.37M	55.48M
Account Payables	8,186B	5.62M	3.86M	2.76M
Deferred Revenue	226B	226K	226K	226K
Short-Term Debt	n/a	-3,375B	n/a	n/a
Other Current Liabilities	11,307B	3,375B	3.96M	3.13M
Total Current Liabilities	11,533B	9.22M	8.05M	6.12M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	45,059B	n/a	n/a	n/a
Total Long-Term Liabilities	45,059B	2.79M	3.02M	3.24M
Total Liabilities	56,592B	12.01M	11.06M	9.36M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	36B	210K	209K	209K
Retained Earnings	-649,154B	-482.63M	-463.68M	-444.72M
Comprehensive Income	-42B	-23K	-33K	-14K
Shareholders Equity	-31,630B	10.67M	28.31M	46.12M
Total Investments	n/a	n/a	n/a	n/a